Enovix (NASDAQ:ENVX) Releases Earnings Results, Beats Estimates By $0.01 EPS

Enovix (NASDAQ:ENVXGet Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.17) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.01, Zacks reports. Enovix had a negative net margin of 1,180.21% and a negative return on equity of 102.19%. Enovix updated its Q1 2025 guidance to -0.210–0.150 EPS.

Enovix Stock Performance

NASDAQ ENVX traded up $0.03 on Wednesday, hitting $11.19. 10,986,991 shares of the company’s stock traded hands, compared to its average volume of 6,868,415. The company has a current ratio of 3.77, a quick ratio of 3.61 and a debt-to-equity ratio of 0.99. The firm’s 50-day moving average price is $11.03 and its two-hundred day moving average price is $10.29. Enovix has a 1-year low of $5.70 and a 1-year high of $18.68. The firm has a market capitalization of $1.99 billion, a PE ratio of -6.95 and a beta of 1.87.

Insider Activity at Enovix

In related news, Director Betsy S. Atkins sold 75,000 shares of the business’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $9.73, for a total value of $729,750.00. Following the completion of the transaction, the director now directly owns 99,497 shares in the company, valued at $968,105.81. The trade was a 42.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 15.70% of the company’s stock.

Wall Street Analysts Forecast Growth

ENVX has been the topic of a number of analyst reports. Benchmark reaffirmed a “buy” rating and issued a $25.00 price objective on shares of Enovix in a research report on Wednesday, October 30th. JPMorgan Chase & Co. lowered their target price on shares of Enovix from $18.00 to $15.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $30.00 target price on shares of Enovix in a research note on Wednesday, October 30th. Finally, Janney Montgomery Scott cut shares of Enovix from a “buy” rating to a “neutral” rating and set a $10.00 target price for the company. in a research note on Thursday, October 31st. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Enovix currently has an average rating of “Moderate Buy” and a consensus target price of $20.50.

Read Our Latest Report on Enovix

Enovix Company Profile

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Featured Stories

Earnings History for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.